BioForm Medical, Inc. (BFRM) Tuesday said it has been granted early termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act, by the U.S. Federal Trade Commission and the U.S. Department of Justice in connection with the previously announced US$5.45 per share cash tender offer made by Merz GmbH & Co. KGaA and its acquisition subsidiary to purchase all outstanding shares of common stock of BioForm Medical, Inc. The tender offer would expire on February 12, 2010.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.